{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T23:39:48Z","timestamp":1771889988995,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background\n<\/jats:title>\n                <jats:p>This study aimed to identify the current risk factors for coronavirus disease 2019 severity and examine its association with medication use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods\n<\/jats:title>\n                <jats:p>We used data from a large United States electronic health record database to conduct an anonymized cohort study of 171,491 patients with coronavirus disease\u00a02019. The study was conducted from January 1, 2020, to August 27, 2021. Data on age, race, sex, history of diseases, and history of medication prescriptions were analyzed using the Cox proportional hazards model analysis to calculate hazard ratios for hospitalization and severe risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Factors that increased the risk of hospitalization and critical care were age\u2009\u2265\u200965\u00a0years, male sex, type 2 diabetes, hypertension, interstitial pneumonia, and cardiovascular disease. In particular, age\u2009\u2265\u200965\u00a0years significantly increased the risk of hospitalization (hazard ratio, 2.81 [95% confidence interval, 2.58\u20133.07]; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and critical care (hazard ratio, 3.45 [2.88\u20134.14]; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In contrast, patients with hyperlipidemia had a reduced risk. However, patients with hyperlipidemia who were not taking statins had a significantly increased risk of hospitalization (hazard ratio, 1.24 [1.16\u20131.34]; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Sodium-glucose cotransporter-2 inhibitors, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, glucocorticoids, and statins significantly reduced the risk of hospitalization and critical care. The risk of hospitalization and critical care increased in patients of all ethnicities with type 2 diabetes. The factors that significantly increased the risk of hospitalization in all regions were older age, hypertension, chronic obstructive pulmonary disease, and cardiovascular disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study identified factors that increase or reduce the risk of severe coronavirus disease. The provision of appropriate drug treatment and modification of lifestyle-related risk factors may reduce coronavirus disease severity.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-16401-4","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T09:01:39Z","timestamp":1691139699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Mitsuki","family":"Jimbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakae","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Uematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Hanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Otori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Shibuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"key":"16401_CR1","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052\u20139. https:\/\/doi.org\/10.1001\/jama.2020.6775.","journal-title":"JAMA"},{"key":"16401_CR2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","volume":"395","author":"MJ Cummings","year":"2020","unstructured":"Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, Clinical Course, and Outcomes of Critically Ill Adults With COVID-19 in New York City: A Prospective Cohort Study. Lancet. 2020;395:1763\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(20)31189-2.","journal-title":"Lancet"},{"key":"16401_CR3","doi-asserted-by":"publisher","first-page":"e2116901","DOI":"10.1001\/jamanetworkopen.2021.16901","volume":"4","author":"TD Bennett","year":"2021","unstructured":"Bennett TD, Moffitt RA, Hajagos JG, Amor B, Anand A, Bissell MM, et al. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative. JAMA Netw Open. 2021;4:e2116901. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.16901.","journal-title":"JAMA Netw Open."},{"key":"16401_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors Associated With COVID-19-Related Death Using OpenSAFELY. Nature. 2020;584:430\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2521-4.","journal-title":"Nature"},{"key":"16401_CR5","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(21)00634-6","volume":"397","author":"R Mathur","year":"2021","unstructured":"Mathur R, Rentsch CT, Morton CE, Hulme WJ, Schultze A, MacKenna B, et al. Ethnic Differences in SARS-CoV-2 Infection and COVID-19-Related Hospitalisation, Intensive Care Unit Admission, and Death in 17 Million Adults in England: An Observational Cohort Study Using the OpenSAFELY Platform. Lancet. 2021;397:1711\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(21)00634-6.","journal-title":"Lancet"},{"key":"16401_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.7326\/M20-8283","volume":"174","author":"C Nau","year":"2021","unstructured":"Nau C, Bruxvoort K, Navarro RA, Chevez SG, Hogan TA, Ironside KR, et al. COVID-19 Inequities Across Multiple Racial and Ethnic Groups: Results From an Integrated Health Care Organization. Ann Intern Med. 2021;174:1183\u20136. https:\/\/doi.org\/10.7326\/M20-8283.","journal-title":"Ann Intern Med"},{"key":"16401_CR7","unstructured":"Bureau USC. Decennial Census of Population and Housing \/by Decade \/2020 Census Decade 2020. Available from: https:\/\/www.census.gov. Accessed 15 Jan 2022."},{"key":"16401_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S2213-8587(21)00050-4","volume":"9","author":"K Khunti","year":"2021","unstructured":"Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N, et al. Prescription of Glucose-Lowering Therapies and Risk of COVID-19 Mortality in People With Type 2 Diabetes: A Nationwide Observational Study in England. Lancet Diabetes Endocrinol. 2021;9:293\u2013303. https:\/\/doi.org\/10.1016\/S2213-8587(21)00050-4.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"16401_CR9","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","volume":"382","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. N Engl J Med. 2020;382:2441\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2008975.","journal-title":"N Engl J Med"},{"key":"16401_CR10","doi-asserted-by":"publisher","first-page":"e213594","DOI":"10.1001\/jamanetworkopen.2021.3594","volume":"4","author":"R Baral","year":"2021","unstructured":"Baral R, Tsampasian V, Debski M, Moran B, Garg P, Clark A, et al. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021;4:e213594.\u00a0https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.3594.\u00a0Epub 20210301.","journal-title":"JAMA Netw Open."},{"key":"16401_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","volume":"32","author":"XJ Zhang","year":"2020","unstructured":"Zhang XJ, Qin JJ, Cheng X, Shen L, Zhao YC, Yuan Y, et al. In-Hospital Use of Statins Is Associated With a Reduced Risk of Mortality Among Individuals With COVID-19. Cell Metab. 2020;32:176-87.e4. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.015.","journal-title":"Cell Metab"},{"key":"16401_CR12","doi-asserted-by":"publisher","first-page":"17968","DOI":"10.1038\/s41598-021-96720-x","volume":"11","author":"W Ando","year":"2021","unstructured":"Ando W, Horii T, Uematsu T, Hanaki H, Atsuda K, Otori K. Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States. Sci Rep. 2021;11:17968. https:\/\/doi.org\/10.1038\/s41598-021-96720-x.","journal-title":"Sci Rep"},{"key":"16401_CR13","doi-asserted-by":"publisher","unstructured":"Ando W, Horii T, Jimbo M, Uematsu T, Atsuda K, Hanaki H, et al. Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States. Front Public Health. 2022;10:985494. https:\/\/doi.org\/10.3389\/fpubh.2022.985494.","DOI":"10.3389\/fpubh.2022.985494"},{"key":"16401_CR14","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","volume":"17","author":"MR Cowie","year":"2020","unstructured":"Cowie MR, Fisher M. SGLT2 Inhibitors: Mechanisms of Cardiovascular Benefit Beyond Glycaemic Control. Nat Rev Cardiol. 2020;17:761\u201372. https:\/\/doi.org\/10.1038\/s41569-020-0406-8.","journal-title":"Nat Rev Cardiol"},{"key":"16401_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/S2213-8587(21)00180-7","volume":"9","author":"MN Kosiborod","year":"2021","unstructured":"Kosiborod MN, Esterline R, Furtado RHM, Oscarsson J, Gasparyan SB, Koch GG, et al. Dapagliflozin in Patients With Cardiometabolic Risk Factors Hospitalised With COVID-19 (DARE-19): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. Lancet Diabetes Endocrinol. 2021;9:586\u201394. https:\/\/doi.org\/10.1016\/S2213-8587(21)00180-7.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"16401_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.aace.2020.11.019","volume":"7","author":"RJ Vitale","year":"2021","unstructured":"Vitale RJ, Valtis YK, McDonnell ME, Palermo NE, Fisher NDL. Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors. AACE Clin Case Rep. 2021;7:10\u20133. https:\/\/doi.org\/10.1016\/j.aace.2020.11.019.","journal-title":"AACE Clin Case Rep"},{"key":"16401_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al. Dulaglutide and Cardiovascular Outcomes in Type 2 Diabetes (REWIND): A Double-Blind. Randomised Placebo-Controlled Trial Lancet. 2019;394:121\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(19)31149-3.","journal-title":"Randomised Placebo-Controlled Trial Lancet"},{"key":"16401_CR18","doi-asserted-by":"publisher","unstructured":"Drucker DJ. Coronavirus Infections and Type 2 Diabetes-Shared Pathways With Therapeutic Implications. Endocr Rev. 2020;41:bnaa011. https:\/\/doi.org\/10.1210\/endrev\/bnaa011.","DOI":"10.1210\/endrev\/bnaa011"},{"key":"16401_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.23736\/S2724-6507.20.03369-6","volume":"46","author":"DE Perez-Montes","year":"2021","unstructured":"Perez-Montes DE, Oca A, Pellitero S, Puig-Domingo M. Obesity and GLP-1. Minerva Endocrinol (Torino). 2021;46:168\u201376. https:\/\/doi.org\/10.23736\/S2724-6507.20.03369-6.","journal-title":"Minerva Endocrinol (Torino)"},{"key":"16401_CR20","doi-asserted-by":"publisher","unstructured":"Nguyen NN, Ho DS, Nguyen HS, Ho DKN, Li HY, Lin CY, et al. Preadmission Use of Antidiabetic Medications and Mortality Among Patients With COVID-19 Having Type 2 Diabetes: A Meta-analysis. Metabolism. 2022;131:155196. https:\/\/doi.org\/10.1016\/j.metabol.2022.155196.","DOI":"10.1016\/j.metabol.2022.155196"},{"key":"16401_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/jama.2019.13772","volume":"322","author":"J Rosenstock","year":"2019","unstructured":"Rosenstock J, Kahn SE, Johansen OE, Zinman B, Espeland MA, Woerle HJ, et al. Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial. JAMA. 2019;322:1155\u201366. https:\/\/doi.org\/10.1001\/jama.2019.13772.","journal-title":"JAMA"},{"key":"16401_CR22","doi-asserted-by":"publisher","unstructured":"Li Y, Yang X, Yan P, Sun T, Zeng Z, Li S. Metformin in Patients With COVID-19: A Systematic Review and Meta-analysis. Front Med (Lausanne). 2021;8:704666. https:\/\/doi.org\/10.3389\/fmed.2021.704666.","DOI":"10.3389\/fmed.2021.704666"},{"key":"16401_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.cmet.2020.08.013","volume":"32","author":"X Cheng","year":"2020","unstructured":"Cheng X, Liu YM, Li H, Zhang X, Lei F, Qin JJ, et al. Metformin Is Associated With Higher Incidence of Acidosis, but Not Mortality, in Individuals With COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020;32:537-47.e3. https:\/\/doi.org\/10.1016\/j.cmet.2020.08.013.","journal-title":"Cell Metab"},{"key":"16401_CR24","doi-asserted-by":"publisher","unstructured":"Crouse AB, Grimes T, Li P, Might M, Ovalle F, Shalev A. Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes. Front Endocrinol. 2020;11:600439. https:\/\/doi.org\/10.3389\/fendo.2020.600439.","DOI":"10.3389\/fendo.2020.600439"},{"key":"16401_CR25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.120.16314","volume":"77","author":"L Semenzato","year":"2021","unstructured":"Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, et al. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients. Hypertension. 2021;77:833\u201342. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16314.","journal-title":"Hypertension"},{"key":"16401_CR26","doi-asserted-by":"publisher","unstructured":"Adir Y, Saliba W, Beurnier A, Humbert M. Asthma and COVID-19: An Update. Eur Respir Rev. 2021;30. https:\/\/doi.org\/10.1183\/16000617.0152-2021.","DOI":"10.1183\/16000617.0152-2021"},{"key":"16401_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","volume":"58","author":"M Yamaya","year":"2020","unstructured":"Yamaya M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K, et al. Inhibitory Effects of Glycopyrronium, Formoterol, and Budesonide on Coronavirus HCoV-229E Replication and Cytokine Production by Primary Cultures of Human Nasal and Tracheal Epithelial Cells. Respir Investig. 2020;58:155\u201368. https:\/\/doi.org\/10.1016\/j.resinv.2019.12.005.","journal-title":"Respir Investig"},{"key":"16401_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12985-021-01604-1","volume":"18","author":"Y Liu","year":"2021","unstructured":"Liu Y, Pan Y, Yin Y, Chen W, Li X. Association of Dyslipidemia With the Severity and Mortality of Coronavirus Disease 2019 (COVID-19): A Meta-analysis. Virol J. 2021;18:157. https:\/\/doi.org\/10.1186\/s12985-021-01604-1.","journal-title":"Virol J"},{"key":"16401_CR29","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.7150\/ijms.62021","volume":"18","author":"Y Tang","year":"2021","unstructured":"Tang Y, Hu L, Liu Y, Zhou B, Qin X, Ye J, et al. Possible Mechanisms of Cholesterol Elevation Aggravating COVID-19. Int J Med Sci. 2021;18:3533\u201343. https:\/\/doi.org\/10.7150\/ijms.62021.","journal-title":"Int J Med Sci"},{"key":"16401_CR30","doi-asserted-by":"publisher","unstructured":"Torres-Pe\u00f1a JD, Katsiki N, Perez-Martinez P. Could Statin Therapy Be Useful in Patients With Coronavirus Disease 2019 (COVID-19)? Front Cardiovasc Med. 2021;8:775749. https:\/\/doi.org\/10.3389\/fcvm.2021.775749.","DOI":"10.3389\/fcvm.2021.775749"},{"key":"16401_CR31","doi-asserted-by":"publisher","unstructured":"Surma S, Banach M, Lewek J. COVID-19 and Lipids. The Role of Lipid Disorders and Statin Use in the Prognosis of Patients With SARS-CoV-2 Infection. Lipids Health Dis. 2021;20:141. https:\/\/doi.org\/10.1186\/s12944-021-01563-0.","DOI":"10.1186\/s12944-021-01563-0"},{"issue":"6","key":"16401_CR32","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s11606-021-06699-4","volume":"36","author":"T Rushovich","year":"2021","unstructured":"Rushovich T, Boulicault M, Chen JT, Danielsen AC, Tarrant A, Richardson SS, et al. Sex Disparities in COVID-19 Mortality Vary Across US Racial Groups. J Gen Intern Med. 2021;36(6):1696\u2013701. https:\/\/doi.org\/10.1007\/s11606-021-06699-4.","journal-title":"J Gen Intern Med"},{"key":"16401_CR33","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1377\/hlthaff.2020.00897","volume":"39","author":"TM Selden","year":"2020","unstructured":"Selden TM, Berdahl TA. COVID-19 And Racial\/Ethnic Disparities In Health Risk, Employment, And Household Composition. Health Aff (Millwood). 2020;39:1624\u201332. https:\/\/doi.org\/10.1377\/hlthaff.2020.00897.","journal-title":"Health Aff (Millwood)"},{"key":"16401_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12889-017-4383-8","volume":"17","author":"T Manyanga","year":"2017","unstructured":"Manyanga T, Tremblay MS, Chaput JP, et al. Socioeconomic status and dietary patterns in children from around the world: different associations by levels of country human development? BMC Public Health. 2017;17:457. https:\/\/doi.org\/10.1186\/s12889-017-4383-8.","journal-title":"BMC Public Health"},{"key":"16401_CR35","doi-asserted-by":"publisher","unstructured":"Clements JM, West BT, Yaker Z, Lauinger B, McCullers D, Haubert J, et al. Disparities in Diabetes-Related Multiple Chronic Conditions and Mortality: The Influence of Race. Diabetes Res Clin Pract. 2020;159:107984. https:\/\/doi.org\/10.1016\/j.diabres.2019.107984.","DOI":"10.1016\/j.diabres.2019.107984"},{"key":"16401_CR36","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1053\/j.ajkd.2021.07.003","volume":"78","author":"EYM Chung","year":"2021","unstructured":"Chung EYM, Palmer SC, Natale P, Krishnan A, Cooper TE, Saglimbene VM, et al. Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2021;78:804\u201315. https:\/\/doi.org\/10.1053\/j.ajkd.2021.07.003.","journal-title":"Am J Kidney Dis"},{"key":"16401_CR37","first-page":"469","volume":"64","author":"K Dominguez","year":"2015","unstructured":"Dominguez K, Penman-Aguilar A, Chang MH, Moonesinghe R, Castellanos T, Rodriguez-Lainz A, et al. Vital Signs: Leading Causes of Death, Prevalence of Diseases and Risk Factors, and Use of Health Services among Hispanics in the United States \u2013 2009\u20132013 Vital Signs. MMWR Morb Mortal Wkly Rep. 2015;64:469\u201378.","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-16401-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-16401-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-16401-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T22:12:28Z","timestamp":1700518348000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-16401-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["16401"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-16401-4","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"21 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of Kitasato University Hospital (No. 20\u2013366). The ethics committee confirmed that all methods were performed in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects in Japan and relevant regulations. The requirement for informed consent was waived by the Ethical Committee of Kitasato University Hospital because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1489"}}